SUPN - Supernus Pharmaceuticals Inc. (SUPN) CEO Jack Khattar on Q1 2021 Results - Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (SUPN) Q1 2021 Earnings Conference Call May 05, 2021, 16:30 ET Company Participants Peter Vozzo - Westwicke Partners Jack Khattar - Founder, President, CEO, Secretary & Director James Kelly - EVP & CFO Conference Call Participants Kenneth Cacciatore - Cowen and Company David Amsellem - Piper Sandler & Co. Nicholas Rubino - Stifel, Nicolaus & Company David Steinberg - Jefferies Presentation Operator Good afternoon, and welcome to Supernus Pharmaceuticals' First Quarter 2021 Financial Results Conference Call. [Operator Instructions]. I would now like to turn the conference over to Peter Vozzo of Westwicke, Investor Relations representative for Supernus Pharmaceuticals. You may begin. Peter Vozzo Thank you, Jurgen. Good afternoon, everyone, and thank you for joining us today for Supernus Pharmaceuticals First Quarter 2021 Financial Results Conference Call. Today, after the close of the market, the company issued a press release announcing these results. On the call with me
For further details see:
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2021 Results - Earnings Call Transcript